Procainamide

DB01035ApprovedSmall moleculeAntiarrhythmic agentsAntiarrhythmics, Class Ia

Procainamide is a medication used to treat life threatening ventricular arrhythmias. A derivative of procaine with less CNS action.

Chemical structure of Procainamide
Mechanism
Curator reviewed
Primary indication
For the treatment of life-threatening ventricular arrhythmias.Curator reviewed · 4 structured indications
Formula / weight
C13H21N3O · 235.3253 g/mol (avg)
First approval
Canada, 2005 · United States, 1976
Code names
NSC-27461

Resolves to

Compound
UNIIL39WTC366DCAS51-06-9ChEMBLCHEMBL640ChEBI8428PubChem4913KEGGC07401
Clinical / RWD
RxNorm8700ATCC01BA02PharmGKBPA451108
Structure
InChIKeyREQCZEXYDRLIBE-UHFFFAOYSA-NSMILESCCN(CC)CCNC(=O)C1=CC=C(N)C=C1
Targets
Q12809KCNH2Q14524SCN5AP26358DNMT1
Transporters
O15244SLC22A2O15245SLC22A1O75751SLC22A3O76082SLC22A5Q9H015SLC22A4Q96FL8SLC47A1Q86VL8SLC47A2

What you can answer from here — as of September 23, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
7TransportersSubstrate / inhibitor direction, not just membership
Listed above
1,762Drug interactionsStructured to mechanism, not free text
Sign in
13Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
59Marketed productsAcross 4 countries and 27 labellers
Sign in
1ATC codeIncluding every combination product, plus 37 drug categories
Sign in
60+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Procainamide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In